SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10QSB - Optional form for quarterly and transition reports of small business issuers:
SEC Accession No. 0000812796-06-000046
Filing Date
2006-08-14
Accepted
2006-08-14 16:05:30
Documents
6
Period of Report
2006-06-30

Document Format Files

Seq Description Document Type Size
1 10QSB DOR 2ND QUARTER 2006 dor2q06.htm 10QSB 401910
2 DOR RISK FACTORS - 2Q 2006 riskfactors2q06.htm EX-99.1 77031
3 CEO CERT 2Q 2006 ceocert-2q06.htm EX-31.1 12111
4 CFO CERT 2Q 2006 cfocert-2q06.htm EX-31.2 12029
5 CEO CERT 906 2Q 2006 ceocert906-2q06.htm EX-32.1 5911
6 CFO CERT 906 2Q 2006 cfocert906-2q06.htm EX-32.2 6139
  Complete submission text file 0000812796-06-000046.txt   516741
Mailing Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139
Business Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139 305-534-3383
DOR BIOPHARMA INC (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10QSB | Act: 34 | File No.: 000-16929 | Film No.: 061030425
SIC: 2834 Pharmaceutical Preparations